Standout Papers

Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagl... 2021 2026 2022 2024139
  1. Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin (2021)
    Koenraad Philippaert, Subha Kalyaanamoorthy et al. Circulation

Immediate Impact

5 by Nobel laureates 25 from Science/Nature 64 standout
Sub-graph 1 of 20

Citing Papers

Arachidonic acid metabolism in health and disease
2023 Standout
Gliflozins in the Management of Cardiovascular Disease
2022 Standout

Works of Peter E. Light being referenced

Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin
2021 Standout
Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure
2020
and 1 more

Author Peers

Author Last Decade Papers Cites
Peter E. Light 2427 960 1481 1361 114 5.5k
Show‐Ling Shyng 3782 2183 844 1757 87 6.2k
Fabio A. Recchia 3500 831 3590 1178 139 8.2k
Takashi Miki 4129 2719 1469 2812 143 8.5k
Coert J. Zuurbier 2042 855 1501 1317 117 5.3k
Howard E. Morgan 3068 599 1533 671 122 6.0k
Christoph Maack 4140 870 3691 797 164 7.6k
Wolfgang Linz 2683 1059 4592 983 150 9.0k
Hao Zhou 5365 1274 1188 796 116 8.6k
Bernward A. Schölkens 2326 1158 4080 506 124 7.7k
Pieter D. Verdouw 1308 1613 2903 1194 210 5.9k

All Works

Loading papers...

Rankless by CCL
2026